Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07539324 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Impact of DCB-based Versus DES-based Intervention in Patients With MVCAD

Study acronym: DCBMultivessel
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Start date changed from estimate of Apr 15, 2026 to Sep 28, 2026 · Completion pushed from Jul 31, 2032 to Dec 31, 2032 · Interventions modified · 4 more Show 7 more changesShow less
    • Start date changed from estimate of Apr 15, 2026 to Sep 28, 2026
    • Completion pushed from Jul 31, 2032 to Dec 31, 2032
    • Interventions modified
    • Study sites: 0 to 1
    • Eligibility criteria expanded, about 41 words
    • Secondary endpoints: details revised at 2 of 12 entries
    • Study description expanded, about 47 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aimes to compare the clinical outcomes of drug-coated balloon-based percutaneous coronary intervention (DCB-based PCI) and drug-eluting stent-based percutaneous coronary intervention (DES-based PCI) in patients with multivessel coronary artery lesions measuring 2.25 mm to 4.0 mm in diameter through a prospective, multicenter, active-controlled, randomized, investigator-initiated clinical trial.
Trial Details
NCT Number NCT07539324
Lead Sponsor Genoss Co., Ltd.
Conditions Multi Vessel Coronary Artery Disease, Percutaneous Coronary Intervention
Enrollment 892 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov